Clinuvel Pharmaceuticals Ltd (CLVLY)
10.00
+0.04
(+0.45%)
USD |
OTCM |
Sep 23, 16:00
Clinuvel Pharmaceuticals Total Liabilities (Quarterly): 18.79M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 18.79M |
| December 31, 2023 | 22.50M |
| June 30, 2023 | 19.25M |
| December 31, 2022 | 14.37M |
| June 30, 2022 | 12.65M |
| December 31, 2021 | 6.061M |
| June 30, 2021 | 7.386M |
| December 31, 2020 | 7.532M |
| June 30, 2020 | 5.410M |
| December 31, 2019 | 2.836M |
| June 30, 2019 | 3.618M |
| December 31, 2018 | 1.818M |
| June 30, 2018 | 2.563M |
| December 31, 2017 | 2.170M |
| June 30, 2017 | 2.431M |
| December 31, 2016 | 1.655M |
| June 30, 2016 | 1.720M |
| December 31, 2015 | 1.816M |
| June 30, 2015 | 1.870M |
| December 31, 2014 | 1.484M |
| June 30, 2014 | 1.625M |
| December 31, 2013 | 1.653M |
| June 30, 2013 | 1.833M |
| Date | Value |
|---|---|
| December 31, 2012 | 3.142M |
| June 30, 2012 | 2.366M |
| December 31, 2011 | 2.631M |
| June 30, 2011 | 4.016M |
| December 31, 2010 | 2.864M |
| June 30, 2010 | 2.591M |
| December 31, 2009 | 2.509M |
| June 30, 2009 | 3.677M |
| December 31, 2008 | 3.790M |
| June 30, 2008 | 3.022M |
| December 31, 2007 | 2.538M |
| June 30, 2007 | 2.062M |
| December 31, 2006 | 1.070M |
| June 30, 2006 | 2.287M |
| December 31, 2005 | 2.015M |
| June 30, 2005 | 1.982M |
| December 31, 2004 | 0.9136M |
| June 30, 2004 | 0.9703M |
| December 31, 2003 | 0.4772M |
| June 30, 2003 | 0.3603M |
| December 31, 2002 | 0.2194M |
| June 30, 2002 | 0.1187M |
| December 31, 2001 | 0.1299M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.836M
Minimum
Dec 2019
22.50M
Maximum
Dec 2023
11.68M
Average
10.09M
Median
Total Liabilities (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 2.345M |
| Kazia Therapeutics Ltd | 13.02M |
| Immutep Ltd | 9.137M |
| Opthea Ltd | 213.41M |
| Mesoblast Ltd | 167.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 154.48M |
| Shareholders Equity (Quarterly) | 135.69M |
| Current Ratio | 8.808 |
| Net Debt Paydown Yield | 0.05% |